| Cloaking nanoparticles with protein corona shield for targeted drug delivery JY Oh, HS Kim, L Palanikumar, EM Go, B Jana, SA Park, HY Kim, K Kim, ... Nature communications 9 (1), 4548, 2018 | 358 | 2018 |
| Engineering tunable dual functional protein cage nanoparticles using bacterial superglue Y Bae, GJ Kim, H Kim, SG Park, HS Jung, S Kang Biomacromolecules 19 (7), 2896-2904, 2018 | 61 | 2018 |
| Development of target‐tunable P22 VLP‐based delivery nanoplatforms using bacterial superglue H Kim, H Choi, Y Bae, S Kang Biotechnology and bioengineering 116 (11), 2843-2851, 2019 | 47 | 2019 |
| Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe H Moon, J Lee, H Kim, S Heo, J Min, S Kang Biomaterials research 18 (1), 21, 2014 | 45 | 2014 |
| Plug-and-playable fluorescent cell imaging modular toolkits using the bacterial superglue, SpyTag/SpyCatcher H Moon, Y Bae, H Kim, S Kang Chemical communications 52 (97), 14051-14054, 2016 | 43 | 2016 |
| Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI YK Song, YJ Kang, H Jung, H Kim, S Kang, HJ Cho Scientific reports 5 (1), 15656, 2015 | 39 | 2015 |
| Development of an antibody-binding modular nanoplatform for antibody-guided targeted cell imaging and delivery H Kim, YJ Kang, J Min, H Choi, S Kang Rsc Advances 6 (23), 19208-19213, 2016 | 31 | 2016 |
| Protein cage nanoparticles as delivery nanoplatforms B Choi, H Kim, H Choi, S Kang Biomimetic Medical Materials: From Nanotechnology to 3D Bioprinting, 27-43, 2018 | 28 | 2018 |
| Fabrication of nanoreaction clusters with dual‐functionalized protein cage nanobuilding blocks H Choi, B Choi, GJ Kim, H Kim, H Kim, HS Jung, S Kang Small 14 (35), 1801488, 2018 | 26 | 2018 |
| A recombinant secondary antibody mimic as a target-specific signal amplifier and an antibody immobilizer in immunoassays J Min, EK Song, H Kim, KT Kim, TJ Park, S Kang Scientific Reports 6 (1), 24159, 2016 | 17 | 2016 |
| Target-switchable Gd (III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI H Kim, S Jin, H Choi, MS Kang, SG Park, H Jun, HJ Cho, S Kang Journal of Controlled Release 335, 269-280, 2021 | 16 | 2021 |
| TRAIL and EGFR Affibody Dual-displayed Lumazine Synthase Protein Cage Enhance Tumorspecific Cell Apoptosis KIM Hansol, JUN Heejin, K Sebyung 한국생물공학회 학술대회, 360-360, 2020 | | 2020 |
| Nano-reaction cluster formation by the Fabrication of the post-translationally functionalized Protein Cage Nanobuilding Blocks C Hyukjun, KIM Hansol, K Sebyung 한국생물공학회 학술대회, 458-458, 2019 | | 2019 |
| Nanoreactor formation through clustering functionalized protein cage nanobuilding blocks H Choi, H Kim, S Kang 한국생체재료학회, 2018 | | 2018 |
| Developing high-field MRI contrast conjugate agents using protein cage nanoparticles H Kim, S Jin, H Choi, H Cho, S Kang American Chemical Society, 2017 | | 2017 |
| Developing cell imaging modular protein cage nanoparticles using protein ligation system Y Bae, H Moon, H Kim, S Kang Nanopia 2016, 2016 | | 2016 |
| Polyvalent and oriented display of targeting antibodies on the surface of protein cage nanoparticles through molecular recognition for effective optical cell imaging H Kim, YJ Kang, J Min, S Kang Gordon Research Conference, 2015 | | 2015 |
